Dr Chalmers Path to Pro - Ozempic and Cancer episode artwork

EPISODE · Jan 29, 2025 · 17 MIN

Dr Chalmers Path to Pro - Ozempic and Cancer

from The Dr. Chalmers Show · host Dr. Matt Chalmers

Concerns about Ozempic and cancer, particularly thyroid cancer, have surfaced, but reports are mostly anecdotal and lack solid research. Many users already have high risk factors like obesity, diabetes, poor diet, and processed food consumption, making it misleading to blame the medication alone.While Ozempic and similar peptides can aid weight loss and metabolic health, misuse can lead to muscle loss, liver issues, and emotional blunting. However, when combined with proper diet and exercise, it may actually reduce cancer risk by improving overall health.Highlights of the Podcast00:04 – Ozempic and Cancer Claims01:45 – Health Risks and Misconceptions03:25 – How GLP-1 Medications Work06:18 – Side Effects and Proper Use08:06 – Thyroid Cancer and Misinterpretation of Data11:23 – Misleading Media Narratives12:56 – Importance of Insulin Regulation14:37 – Insulin Resistance and Dementia

Episode metadata supplied by the publisher feed · Published Jan 29, 2025

Embed this episode

NOW PLAYING

Dr Chalmers Path to Pro - Ozempic and Cancer

0:00 17:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Dr. Chalmers Show?

This episode is 17 minutes long.

When was this The Dr. Chalmers Show episode published?

This episode was published on January 29, 2025.

Can I download this The Dr. Chalmers Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!